Alex M Parker, MD : Research

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to…

Investigator

Alex M Parker

Status

Accepting Candidates

Ages

18 Years - 130 Years

Sexes

All

The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on myocardial recovery and clinical outcomes. Given…

Investigator

Alex M Parker

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

Female

A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced…

Investigator

Alex M Parker

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All